Clinical information of the eligible trials for the meta-analysis.

The table summarizes the patients' basic information about the tumor stage, newly or recurrent, cases, age, KPS, operative method before the immunotherapy and details of the immunotherapy including the DC, tumor antigen, and loading route. The last row is the culture conditions used for the cells. KPS: Karnofsky performance status; AIT: Autologous irradiated tumor cells; ATL: Autologous tumor lysate; HLP: HLA-1-eluted peptides; ATP: Autologous acid-eluted tumor peptides; AHT: Autologous heat-shock tumor cells; CT: Chemical therapy; RT: Radiation therapy; SR: Surgical resection; KLH: Keyhole limpet hemocyanin; PGE2: Prostaglandin E2; TNF-α: Tumor necrosis factor-α; IL-4: Interleukin-4; i.d.: intradermalvaccination; i.t.: intratumoral vaccination; s.c.:subcutaneous injection; ICH: intra-cellular hyperthermia; UK: Unknown. Clinical information of the eligible trials for the meta-analysis.